<DOC>
	<DOCNO>NCT03058419</DOCNO>
	<brief_summary>The main purpose study determine potential inhibitory/inducing effect JNJ-54175446 single repeat dose single-dose pharmacokinetics ( PK ) cocktail , contain selective probe cytochrome P450 ( CYP ) enzymes ( CYP3A4/A5 , CYP2C9 , CYP1A2 , CYP2D6 , CYP2B6 , CYP2C19 ) healthy adult subject .</brief_summary>
	<brief_title>A Study Evaluate Effect Oral Doses JNJ-54175446 Inhibition Cytochrome P450 CYP3A4 , CYP2C9 , CYP1A2 CYP2D6 Activity Induction CYP2B6 CYP2C19 Activity Using Multiple Probe Substrate Cocktail Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Dextromethorphan</mesh_term>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Subject must body mass index ( BMI ) 18.0 30.0 kilogram per meter square ( kg/m^2 ) , inclusive ( BMI = weight/height^2 ) Subject must healthy basis physical examination , medical history , vital sign , triplicate 12lead electrocardiogram ( ECGs ) , include QTc accord Fridericia 's formula ( QTcF ) less equal ( &lt; /= ) 450 millisecond ( m ) males &lt; /= 470 m female , perform screen first admission study site Subject must healthy basis clinical laboratory test perform screen Day 1 . If result hematology , serology , serum chemistry ( exclude liver function test , must normal range 1.25 * upper limit normal laboratory range ) , coagulation panel , urinalysis outside normal reference range , subject may include investigator judge abnormality clinically significant During study minimum 1 spermatogenesis cycle ( define approximately 90 day ) receive last dose study drug , male subject : Who sexually active woman childbearing potential vasectomy must agree use barrier method contraception ( eg , condom spermicidal foam/gel/film/cream/suppository partner occlusive cap [ diaphragm cervical/vault cap ] spermicidal foam/gel/film/cream/suppository ) . In addition , female partner also use highly effective method birth control ( example , hormonal contraception ) least duration . Who sexually active woman pregnant must use condom Must agree donate sperm A female subject must nonchildbearing potential screening Subject history current liver renal insufficiency ( estimate creatinine clearance 60 milliliter per minute ( mL/min ) , significant skin disease , limited , dermatitis , eczema , StevensJohnson Syndrome , drug rash , psoriasis urticaria , significant cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic ( include coagulation disorder ) , rheumatologic , psychiatric , metabolic disturbance , inflammatory illness illness investigator considers exclude subject Subject history hepatitis B surface antigen ( HBsAg ) hepatitis C antibody ( antiHCV ) positive , clinically active liver disease , test positive HBsAg antiHCV screen Subject history human immunodeficiency virus ( HIV ) antibody positive , test positive HIV screening Subject history malignancy within 5 year screen ( exception squamous basal cell carcinoma skin carcinoma situ cervix , malignancy , opinion investigator , write concurrence sponsor 's medical monitor , consider cure minimal risk recurrence ) Subject history drug alcohol use disorder accord Diagnostic Statistical Manual Mental Disorders ( DSMV ) criterion within 6 month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>